Skip to main content
Medicine logoLink to Medicine
. 2025 Aug 8;104(32):e43802. doi: 10.1097/MD.0000000000043802

Acupuncture for benign prostatic hyperplasia in the elderly: A systematic review of acupoints

Chen Guo a, Lifeng An b, Geling Lu b, Jingwen Huang b,*
PMCID: PMC12338299  PMID: 40797416

Abstract

Background:

Benign prostatic hyperplasia (BPH) affects >50% of males aged ≥50 years, causing lower urinary tract symptoms that significantly impair quality of life. While acupuncture is increasingly used for BPH management, its acupoint selection patterns remain unstandardized.

Methods:

Clinical studies on acupuncture/moxibustion for BPH published before September 30, 2024, were retrieved from CNKI, WANFANG, VIP, PubMed, and ScienceDirect. Acupoint patterns were analyzed using the Traditional Chinese Medicine Inheritance Assistance Platform (TCMISS).

Results:

Among 270 articles, 85 met the inclusion criteria. Sixty-one acupoints were identified, with high-frequency selections including Guanyuan (CV4), Zhongji (CV3), Sanyinjiao (SP6), Qihai (CV6), Shenshu (BL23), Shuidao (ST28), Pangguangshu (BL28), Yinlingquan (SP9), Qugu (CV2), and Ciliao (BL32). The Conception Vessel (CV), Bladder (BL), and Spleen (SP) meridians were predominantly used, primarily distributed in the chest/abdomen (EX-CA) and back/waist (EX-BW) regions. Association rule analysis revealed strong correlations among acupoints, with key combinations being Zhongji (CV3)-Sanyinjiao (SP6), Guanyuan (CV4)-Qihai (CV6), and Guanyuan (CV4)-Sanyinjiao (SP6). Core therapeutic clusters centered on Zhongji (CV3), Guanyuan (CV4), and Shenshu (BL23), integrated with Sanyinjiao (SP6), Shuidao (ST28), and Yinlingquan (SP9).

Conclusions:

Acupuncture for BPH primarily targets CV4, CV3, SP6, CV6, BL23, ST28, BL28, SP9, CV2, and BL32, reflecting their strong therapeutic relevance. These findings highlight meridians and acupoints potentially critical for symptom alleviation. However, rigorous clinical trials are warranted to validate efficacy and optimize protocols. This review provides a foundation for advancing evidence-based acupuncture interventions in BPH management.

Keywords: acupoints statistical, acupuncture, benign prostatic hyperplasia in the elderly, clustering analysis

1. Introduction

Benign prostatic hyperplasia (BPH) is a degenerative urinary disease with high incidence in middle-aged and elderly men worldwide.[13] The pathological features of BPH are characterized by overactive urinary tract symptoms (lower urinary tract symptoms (LUTS)) caused by an imbalance in prostate mesenteric-epithelial cell proliferation, including bladder irritation symptoms such as frequency, urgency, and nocturia, prolonged urination time, intermittent urinary flow, and progressive dysuria.[4,5] Epidemiological data show that BPH is the most common urinary disease and seriously affects the quality of life (QOL) of elderly men, with an age-standardized prevalence of 50% to 75% in men aged ≥50 years and a significant age-dependent increase (up to 82% in those aged ≥70 years).[6,7] With the aging of the population, the limitations of traditional Western medical treatment (such as drugs and surgery) have gradually emerged: α-receptor blockers easily cause orthostatic hypotension, 5α-reductase inhibitors have the risk of sexual dysfunction, and minimally invasive surgery is effective; however, postoperative complications and high cost limit its popularity.[8] In the era of Precision Medicine 2.0, the diagnosis and treatment of BPH are undergoing a paradigm shift from lesion removal to microenvironment remodeling.[9,10] Therefore, as the “green therapy,” acupuncture has gradually become a hot research topic in international urology due to its high safety, few side effects, and overall regulatory advantages.[1113]

The latest progress in evidence-based medical research shows that acupuncture has formed a multi-dimensional evidence chain in the field of BPH treatment.[14] In a randomized controlled trial involving 100 patients with moderate and severe BPH, electroacupuncture significantly improved the International Prostate Symptom Score (IPSS).[15,16] At week 6, the reduction in IPSS in the treatment group was 4.51 (P < .001) higher than that in the control group. At week 18, an increase of 3.2 points in IPSS reduction was found in the treatment group (P = .001), indicating that EA improved patients’ QOL, and acupoints demonstrated superior efficacy to non-acupoints in treating BPH.[15] Acupuncture-moxibustion is effective and safe for treating BPH of different degrees (mild, moderate, and severe) and LUTS caused by BPH.[17,18] At present, there are 3 innovative trends in the clinical practice of acupuncture and moxibustion for BPH: the innovation of acupuncture and devices (the optimization of electroacupuncture parameters, the warming effect of fire needling, and the penetrating needling technique of elongated needles), improved needling techniques (a study on the effect difference between deep needling (≥75 mm) and shallow needling (≤25 mm) at the sacral acupoints of Ciliao (BL32) and Zhongliao (BL33), and combined therapy (acupuncture, moxibustion, and acupoint injection).[16,17,1921] Among these, electroacupuncture therapy provides space for the optimization of acupuncture parameters in clinical applications. Deep needling (approximately 60–75 mm) and shallow needling (approximately 25–40 mm) BL 32 and BL 33 can improve LUTS. Deep EA at BL 32 and BL 33 can significantly enhance the scores of international prostate symptoms (IPSS decreased ≥10.51 points) and QOL in patients with BPH.[16] It is worth noting that current research on the acupoint compatibility rules of acupuncture and moxibustion in treating BPH has obvious limitations. Although “Guanyuan” (CV 4), “Zhongji” (CV 3), and “Sanyinjiao” (SP 6) have been widely established as the core acupoints, the acupoint matching schemes of different academic schools and regional characteristics are significantly heterogeneous in clinical practice. What is more outstanding is that the existing studies are mostly limited to the biological mechanism of the single acupoint effect and lack a systematic study on the dynamic association model of “acupoint-meridian-zangfu,” and generally ignore the individualized regulation needs of patients’ constitution classification and disease course stage. Based on this, this study integrated the prescription mining, complex network analysis, and data visualization modules of the TCM inheritance computing platform to analyze the acupoint selection rules of BPH acupuncture and moxibustion treatment through multi-dimensional analysis (frequency statistics → association rules → entropy clustering), focusing on screening high-frequency acupoint combinations with a synergistic effect. This study provides data support for precise and individualized acupoint prescription optimization in clinical practice, which has important practical value in improving the stability of therapeutic effects and reducing medical costs.

2. Data and methods

2.1. Sources of information

A comprehensive literature search was conducted without restrictions on language. Systematic searches were performed across Chinese databases (CNKI, WANFANGDATA, and VIP) and international databases (PubMed, ScienceDirect), supplemented by other relevant sources. For Chinese databases, the search strategy utilized the Boolean query (“前列腺增生” OR “BPH”) AND (“针灸” OR “针刺” OR “艾灸”), restricted to clinical studies published before September 30, 2024. For English databases, the strategy employed (“prostatic hyperplasia” OR BPH) AND (acupuncture OR acupoint* OR moxibustion), with results filtered to include clinical trials published before September 30, 2024.

No relevant studies were identified in PubMed and ScienceDirect. This finding may be attributable to several factors: First, a significant language bias exists, as the majority of clinical trials investigating acupuncture for BPH are predominantly published in Chinese-language journals. Second, limitations in the search strategy, particularly the reliance on English keywords, may have failed to capture studies employing alternative terminology (e.g., “prostate hyperplasia” without the “benign” qualifier) or region-specific nomenclature for acupoints. Third, there appears to be limited availability of clinical trials conducted in other country settings specifically examining BPH-targeted acupoint combinations. In addition, the disciplinary focus within the English urological literature tends to prioritize pharmacological and surgical treatment over complementary and alternative therapies, such as acupuncture. Collectively, these factors underscore the critical importance of integrating cross-lingual and cross-cultural research approaches in future investigations of acupuncture for BPH.

2.2. Inclusion criteria

  1. Patients with a clear diagnosis of BPH regardless of race, condition, or intensity;

  2. clinical reports on the use of acupuncture in the treatment of BPH;

  3. clear syndrome differentiation and acupoint prescription;

  4. The types of interventions that included combination treatments, such as tuina therapy, physiotherapy, and placebo, were retained.

2.3. Exclusion criteria

  1. The treatment methods were eye acupuncture, ear acupuncture, 7-star needle acupuncture, acupotomology, warm needling therapy, blade acupuncture, or balance acupuncture.

  2. News reports and lectures;

  3. Articles that cannot be identified only by the abstract and the full text are difficult to obtain.

  4. EndNote software was used to eliminate duplicate studies, and only 1 article was used for data extraction.

2.4. Literature screening

The searched literature was independently screened according to the inclusion and exclusion criteria, the extracted data were cross-checked, and disagreements were resolved through internal discussion. The title and abstract were read first, after which the full text was read to determine whether they could be included in the study. The names of the acupoints were standardized. According to the data specification, the “National Standard Acupoint Names and Location of the People’s Republic of China,” the Nomenclature, and the location of meridian points.

2.5. Data processing

The selected data were used to establish an acupoint prescription database imported into the Chinese Medicine inheritance auxiliary platform for descriptive and association rule analysis. Association rules can uncover the mutual influence and causal structure among item sets within a large amount of data. An item set pattern that meets and exceeds the degree of support is regarded as a frequent item set. Through the analysis of frequent item sets, high-frequency acupoint combinations in acupuncture treatment prescriptions can be summarized, and the combination rules can be inferred. In the analysis of association rules, the number of support degrees represents the frequency of the simultaneous occurrence of acupoints X and Y, the support degree represents the frequency of the simultaneous presence of acupoints X and Y, and the confidence degree represents the probability of the appearance of acupoint Y when acupoint X emerges (the closer this parameter is to 1, the higher the probability of the appearance of 1 acupoint following the appearance of the other). Based on the abovementioned method, acupoints with close connections in acupuncture treatment prescriptions can be identified, namely, commonly used acupoint combinations.

2.6. Management of lost data

When important data is missing, attempt to contact the corresponding author.

2.7. Ethical considerations

This study is a systematic review of published literature and does not involve direct collection of human or animal data. According to international guidelines for systematic reviews (PRISMA-ScR), ethical approval and patient consent are not required for such studies.

3. Results and discussion

3.1. Literature search results

A total of 270 relevant articles were retrieved, including 195 from CNKI, 39 from Wanfang Database, and 31 from VIP Database. No relevant articles were found in PubMed and ScienceDirect. The original data downloaded were verified by 2 members (An LF and Lu GL). The flowchart of the study inclusion is shown in Figure 1. After verification, the data were imported into the Traditional Medicine Inheritance Auxiliary Platform (TCMISS) for subsequent analysis.

Figure 1.

Figure 1.

Flow chart of literature screening. A total of 270 articles were retrieved from CNKI, WANFANG, and VIP databases. After removing duplicates and applying inclusion/exclusion criteria, 85 articles were included for analysis. Boxes represent stages of screening (identification, screening, eligibility, inclusion). Arrows indicate the flow of study selection, with exclusion reasons noted (e.g., nonrelevant interventions, unavailable full texts). CNKI = China National Knowledge Infrastructure, VIP = VIP database, WANFANG = WANFANG data.

3.2. Statistical analysis of the frequency of acupoints

The TCMISS traditional Chinese medicine (TCM) inheritance auxiliary platform was used to calculate the frequency of 85 articles that met the criteria. A total of 450 occurrences of acupoints were included, with 61 unique acupoints. Acupoints were sorted according to their frequency of occurrence. Due to the excessive number of acupoints, only those used more than 9 times were included in this study, as shown in Table 1. According to the analysis of the results of acupoint selection, Guanyuan (CV4), with the most frequent acupoint selection, belongs to the conception vessel (CV), which is located in the lower abdomen, 3 cun in the middle and lower umbilicus, and the anterior midline. Guanyuan (CV4) is the alarm point of the small intestine and the crossing point between the CV and the meridians of the liver, spleen, and kidney. Detrusor dysfunction is one of the manifestations of bladder dysfunction in patients with BPH is detrusor dysfunction.[22] Detrusors are not controlled or contracted in a timely and effective manner, which leads to frequent urination and endless urination.[23] Zhongji (CV3) is the acupoint of the CV, which is located in the lower abdomen, 4 cun in the middle and lower umbilicus, and anterior median line. Zhongji (CV3) is the alarm point of the bladder and the crossing point between the CV and the meridians of the liver, spleen, and kidney. The inferior nerve at the Zhongji (CV3) and Guanyuan (CV4) points originates from T12-L1, which contains the pelvic nerve that innervates the bladder detrusor. Acupuncture at Zhongji (CV3) stimulates the parasympathetic nerve and inhibits the sympathetic nerve, resulting in contraction of the bladder detrusor and relaxation of the internal sphincter. It can also improve the function of the bladder detrusor, promote the timely autonomous discharge of urine, and relieve the symptoms of frequent and endless urination.[24]

Table 1.

Frequency of acupoints.

Acupoint Frequency Proportion (Total frequency = 450) (95% CI) Acupoint Frequency Proportion (Total frequency = 450) (95% CI)
CV4 59 13.1% (10.3–16.5) SP9 17 3.8% (2.3–6.0)
CV3 52 11.6% (8.9–14.7) CV2 17 3.8% (2.1–5.5)
SP6 33 7.3% (5.1–10.1) BL32 16 3.6% (2.1–5.7)
CV6 31 6.9% (4.7–9.6) BL54 14 3.1% (1.5–4.7)
BL23 29 6.4% (4.4–9.0) KI3 12 2.7% (1.2–4.2)
ST28 23 5.1% (3.3–7.5) LR3 9 2.0% (0.7–3.3)
BL28 19 4.2% (2.6–6.5) ST36 9 2.0% (0.7–3.3)

Proportion = FrequencyTotalfrequency × 100%. The 95% confidence interval was calculated using the Wilson score method.

BL = bladder meridian, CI = confidence interval, CV = conception vessel, KI = kidney meridian, LR = liver meridian, SP = spleen meridian, ST = stomach meridian.

Sanyinjiao (SP6) belongs to the spleen meridian (SP). It is located at the medial side of the calf, 3 cm above the tip of the medial malleolus, and behind the medial edge of the tibia. This is the crossing point of the liver, spleen, and kidneys. Qihai (CV6) is an acupoint of the CV, which is located in the lower abdomen, 1.5 cun below the umbilicus and on the anterior midline. Shenshu (BL23) is a point on the bladder meridian (BL), located in the lumbar region of the back, specifically 1.5 cun lateral to the posterior midline, beneath the spinous process of the second lumbar vertebra (L2). The high-frequency selection of CV3 and CV4 reflects their neuroanatomical relevance: These acupoints overlie the T12–L1 spinal segments that innervate the bladder detrusor muscle. Stimulation here enhances parasympathetic activity, promoting detrusor contraction and sphincter relaxation – directly addressing BPH-related urinary retention.[24] Similarly, BL23 correlates with sacral micturition centers (S2–S4), regulating bladder storage/voiding reflexes.[25]

3.3. Statistical analysis of meridian frequency

According to the statistical results of the frequency of acupoints, the meridians and acupoints were classified into 12 meridians. As shown in Figure 2, the most frequently involved meridians were the CV (173), bladder meridian (BL) (120), and spleen meridian (SP) (55). The lung meridian (LU), pericardium meridian (PC), triple energizer meridian (TE), large intestine meridian (LI), and gallbladder meridian (GB) were not more than 2 times.

Figure 2.

Figure 2.

Bar chart of the frequency of meridian application. The CV, BL, and SP were the most frequently used meridians, with frequencies of 173, 120, and 55, respectively. Y-axis: frequency; X-axis: meridians. Error bars represent 95% confidence intervals (Wilson Score method). BL = bladder meridian, CV = conception vessel, SP = spleen meridian.

The most frequently treated acupoints were Guanyuan (CV4) at the CV, Zhongji (CV3), and Sanyinjiao (SP6) at the spleen meridian (SP), with 59, 52, and 33 times, respectively, as shown in Table 2. Guanyuan (CV4) and Zhongji (CV3) are the most commonly used acupoints in the CVs. CV, which was consistent with the results of a previous statistical analysis of the acupoint frequency. These results indicate that CV acupoints are more frequently used in the treatment of BPH in the elderly. The effect of acupuncture on the regulation of urination function is closely related to the local neuroanatomical structure of the selected acupoints. The peripheral nervous system that controls the bladder and urethra mainly includes the pelvic, lower abdominal, and perineal nerves.[2527] Studies have found that the nerves near the acupuncture points that affect urethral function project to the spinal cord segments from L1 to S5, which is highly consistent with the segment of the urethral nerve entering the spinal cord.[28] The CV was first recorded in Huangdi Neijing (Yellow Emperor’s Internal Canon), the sea of Yin vessels, including any Yin vessels in the body. The CV runs from the lower abdomen, down the perineum, and upward through the pubis. TCM theories suggest that BPH is related to the imbalance of Yin and Yang in the kidney, spleen, and other viscera. By regulating the CV qi and blood, Yin of the human body can be regulated to improve the local qi and blood state of the prostate. If the qi and blood of the CV are not smooth, this may lead to qi and blood stasis in the lower jiao, including the pelvic part where the prostate is located. Acupuncture at the points of the CV can play a role in clearing qi and blood, improving the blood circulation of the prostate, and reducing the compression of the surrounding tissues, such as the urethra, byhyperplasia tissue.[29] The bladder meridian (BL) is located outside and inside the bladder bowels. Patients with BPH often have voiding dysfunction, such as frequent urination, urgency, and incontinence, and the relaxation function of the bladder is closely related to these voiding symptoms. The gasification function of the bladder can be regulated by acupuncture at the bladder meridian (BL). The patency of qi and blood at the bladder meridian (BL) also helps reduce local qi and blood stasis and relieve discomfort symptoms such as pain caused by prostatic hyperplasia. Acupuncture at the spleen meridian (SP) can invigorate the spleen and reduce dampness, help to improve the metabolism of water and fluid in the body, reduce local edema and other conditions that may be accompanied by prostatic hyperplasia, and improve urination and other related symptoms. The stomach meridian (ST) has a wide circulation range in the human body, and its qi and blood circulation can affect multiple body parts. Although the stomach meridian does not pass directly through the prostate, it is closely related to the circulation of qi and blood in the abdomen. According to the principle of “where the meridians pass, the indications are,” acupuncture at the points of the stomach meridian can regulate the overall circulation of qi and blood in the abdomen and improve the qi and blood state in the pelvis, where the prostate is located. Kidney Yang is one of the fundamentals of Yang qi in the human body, and the governing vessel is closely related to the kidney. In terms of physiological function, the warming effect of kidney yang is essential for maintaining the normal function of the urinary system, including the prostate. When the kidney yang is insufficient, urinary system diseases, such as prostatic hyperplasia, may occur. Acupuncture at the governor vessel point can stimulate Yang qi and promote circulation and distribution. Sufficient Yang qi can warm the lower jiao, improve the local blood circulation of the prostate, and reduce pathological states such as cold coagulation and blood stasis caused by prostatic hyperplasia, thereby improving symptoms such as poor urination caused by prostatic hyperplasia. In addition, the liver meridian (LR) and gallbladder meridian (GB) encircle the perineum, whereas the prostate, a part of the male reproductive system, is located in the pelvic cavity. According to TCM principles, acupoints along the liver (LR) and gallbladder (GB) meridians exhibit topographical correspondence with the prostate region. Stimulation of these acupoints is theorized to modulate local neurovascular activity, enhance pelvic circulation, and reduce prostatic tension. This neuromodulatory effect may alleviate discomfort associated with BPH and contribute to functional improvements in urinary symptoms. The dominance of the CV aligns with its trajectory through the prostate region. CV acupoints resolve Qi stagnation and blood stasis in the lower jiao – a core TCM pathogenesis in BPH.[29] Concurrently, spleen meridian points like SP6 eliminate “dampness accumulation” (key etiology for LUTS), synergizing with CV’s local action through the triple-Yin confluence.

Table 2.

Frequency of meridians.

Meridian Acupoint Frequency Meridian Acupoint Frequency
BL (121) BL23 29 ST (42) ST28 23
BL28 19 ST36 9
BL32 16 ST29 6
BL54 14 ST25 2
BL33 8 ST40 1
BL35 6 ST30 1
BL22 6 KI (30) KI3 12
BL18 4 KI11 5
BL31 3 KI12 4
BL34 3 KI1 2
BL17 3 KI10 2
BL20 3 KI2 1
BL13 1 KI8 1
BL15 1 KI6 1
BL57 1 KI7 1
BL40 1 KI13 1
BL25 1 SP (55) SP6 33
BL27 1 SP9 17
BL26 1 SP10 5
CV (173) CV4 59 LR (12) LR3 9
CV3 52 LR2 2
CV6 31 LR5 1
CV2 17 LU (4) LU7 3
CV8 5 LU5 1
CV12 4 GV (27) GV4 3
CV10 2 GV20 2
CV9 1 GV3 1
CV5 1 GB (1) GB43 1
CV1 1 LI (1) LI4 1
PC (3) PC6 2 TE (2) TE6 2
PC7 1

BL = bladder meridian, CV = conception vessel, GB = gallbladder meridian, GV = governor vessel, KI = kidney meridian, LI = large intestine meridian, LR = liver meridian, LU = lung meridian, PC = pericardium meridian, SP = spleen meridian, ST = stomach meridian, TE = triple energizer meridian.

Based on the above analysis, the CV and bladder meridian (BL) are central in treating BPH and show significant clinical application value.

3.4. Statistical analysis of the acupoints distribution in human body parts

Acupoint distribution was categorized into the following regions: head and neck (EX-HN), back and waist (EX-BW), upper extremities (EX-UE), lower extremities (EX-LE), and chest and abdomen (EX-CA). The distribution patterns are presented in Table 3. The results showed that the total number of acupoints selected was 450. The most frequently chosen acupoints were located at the chest and abdomen (EX-CA) 215 times (47.8% of the total frequency), and the total number of acupoints was 17, which is consistent with the principle of proximal acupoint selection. Acupoints were selected from the chest and abdomen. The abdominal acupoints (EX-CA) were more frequent in Guanyuan (CV4) (59), Zhongji (CV3) (52), Qihai (CV6) (31), Shuidao (ST28) (23), and Qugu (CV2) (17). The second most frequently selected acupoint was back and waist (EX-BW), 123 times in total, accounting for 27.3% of the total frequency, and the total number of acupoints selected was 19. Regarding acupoint selection of points of the back and waist (EX-BW), the principle of acupoint selection based on syndrome differentiation, symptomatic acupoint selection, and distal acupoint selection in the treatment of prostatic hyperplasia was met. The most frequently used acupoints on the back and waist (EX-BW) were Shenshu (BL23) (29), Pangguangshu (BL28) (19), Ciliao (BL32) (16), and Zhibian (BL54) (14). The acupoints of the chest and abdomen (EX-CA) and of the chest and abdomen (EX-CA) embody the treatment principle of combining proximal and distal acupoints, syndrome differentiation, and symptomatic acupoint selection. The frequency of acupoint selection at the points of the head and neck (EX-HN) was the least, 2 times, accounting for 0.4% of the total frequency. According to the results of the analysis of the acupoints mentioned above, the most frequently used acupoints were also distributed in the chest and abdomen (EX-CA) and back and waist (EX-BW). This proves that the points of the chest and abdomen (EX-CA) and back and waist (EX-BW) play a key role in treating BPH in the elderly, showing their significant potential as research objects.

Table 3.

Distribution of acupoints by body region.

Body region Frequency Proportion (95% CI)
EX-CA 215 47.8% (43.1–52.5)
EX-BW 123 27.3% (23.3–31.7)
EX-LE 100 22.2% (18.5–26.3)
EX-UE 10 2.2% (1.1–4.0)
EX-HN 2 0.4% (0.1–1.5)

Proportion = FrequencyTotalfrequency × 100%. The 95% confidence interval was calculated using the Wilson Score method. The bold values highlight the 2 most frequently selected body regions for acupoints in treating benign prostatic hyperplasia (BPH) in the elderly: the EX-CA with a frequency of 215 (47.8%) and the EX-BW with 123 (27.3%). This emphasis underscores their clinical significance, as these regions align with the traditional Chinese medicine principle of “proximal acupoint selection” for lower urinary tract disorders, directly targeting the anatomical and functional areas related to the prostate and bladder. Their high frequency reflects their core role in regulating qi and blood in the lower jiao, supporting the therapeutic focus on these regions in acupuncture protocols for BPH.

CI = confidence interval, EX-BW = back/waist, EX-CA = chest/abdomen, EX-HN = head/neck, EX-LE = lower extremities, EX-UE = upper extremities.

3.5. Frequency statistics of specific points usage

In addition to the indications of general acupoints, specific points also have functions of stronger pertinence, closer connection with zang-fu organs, more effectiveness in particular diseases and symptoms, and a wider regulation range. In clinical practice, specific points are often used to treat prostatic hyperplasia. According to the nature of the particular points, acupoints are divided into 5 transport points: source, crossing, and acupoints. Connecting point, cleft point, transport point, alarm point, confluence points of the 8 vessels, and lower sea points of the prostate, 6 bowels, and 8 meeting points.

Data analysis was performed on the literature that met the standards, with a total of 55 Specific Points − 477 times. The usage frequency of each point is drawn into a bar chart, as shown in Figure 3. In BPH treatment, the crossing point was the most frequently used acupoint (179), including 11 acupoints. The most frequently used acupoints were Guanyuan (CV4), Zhongji (CV3), Sanyinjiao (SP6), and Qugu (CV2), as shown in Table 4. The results showed that Guanyuan (CV4) had the highest frequency, and Guanyuan (CV4) also belonged to the alarm point (118) with high frequency. Therefore, Guanyuan (CV4) can achieve a very good curative effect in the treatment of PH. As the most frequent crossing point, CV4 integrates liver/spleen/kidney meridians. This allows simultaneous regulation of multiple zang-fu systems involved in BPH: liver Qi stagnation (voiding difficulty), spleen dampness (urinary turbidity), and kidney deficiency (nocturia).[29]

Figure 3.

Figure 3.

Analysis of the usage of specific acupoints. Bar chart showing the frequency of specific acupoint categories (crossing points, alarm points, 5 transport points, etc) in BPH treatment. The crossing point category (179 occurrences) was most prevalent. Colors denote different acupoint types (e.g., blue for crossing points, red for alarm points). BPH = benign prostatic hyperplasia, CV = conception vessel.

Table 4.

Frequency of use of specific points.

Specific Point Acupoint Frequency Specific Point Acupoint Frequency
Five transport points (61) PC7 1 Confluence points of the 8 vessels (6) PC6 2
ST36 9 KI6 1
KI3 12 LU7 3
KI1 2 Eight meeting points (7) CV12 4
KI10 2 BL17 3
KI2 1 Source point (23) PC7 1
KI7 1 KI3 12
TE6 2 LR3 9
SP9 17 LI4 1
LR3 9 Alarm point (118) ST25 2
LR2 2 CV4 59
LU5 1 CV3 52
GB43 1 CV12 4
BL40 1 CV5 1
Lower sea points of the 6 bowel (10) ST36 9 Connecting point (7) PC6 2
BL40 1 ST40 1
Crossing point (179) ST30 1 LR5 1
KI11 5 LU7 3
KI12 4 Transport point (65) BL23 29
KI13 1 BL28 19
CV4 59 BL22 6
CV3 52 BL18 4
CV2 17 BL20 3
CV12 4 BL13 1
CV10 2 BL15 1
CV1 1 BL25 1
SP6 33 BL27 1
Cleft point (1) KI8 1

BL = bladder meridian, CV = conception vessel, GB = gallbladder meridian, KI = kidney meridian, LI = large intestine meridian, LR = liver meridian, LU = lung meridian, PC = pericardium meridian, SP = spleen meridian, ST = stomach meridian, TE = triple energizer meridian.

3.6. Frequency statistics of acupoint combinations

Among the 85 articles that met the criteria, only 2 used a single acupoint. A combination of multiple acupoints usually involves acupuncture and moxibustion. To explore the relationship between acupuncture and moxibustion, a multi-acupoint combination was performed using the TCM inheritance assistance platform. The support degree was set at 12, the confidence degree was ≥0.6, and 185 acupoint combinations of acupuncture for BPH were obtained. The most frequently used combinations are Zhongji (CV3) and Sanyinjiao (SP6). Guanyuan (CV4), Qihai (CV6); “Guanyuan (CV4), Sanyinjiao (SP6),” with the frequency of 40, 27, 26, and 24, respectively, as shown in Table 5. CV3 + SP6: CV3 (local alarm point) clears lower jiao stasis, while SP6 (distal point) resolves dampness systemically. This embodies the TCM strategy “treat local symptoms + resolve root cause.” CV4 + CV6: Dual CV points synergistically tonify original Qi to improve bladder contractility in elderly BPH with kidney deficiency.[21]

Table 5.

Frequency of acupoint combination.

Combination of acupoints Frequency Combination of acupoints Frequency Combination of acupoints Frequency
CV4, CV3 40 CV3, CV6 20 CV4, CV3, CV6 16
CV3, SP6 27 CV4, ST28 20 BL23, BL28 16
CV4, CV6 26 CV4, CV3, SP6 20 CV4, CV3, ST28 16
CV4, SP6 24 CV3, ST28 19 CV4, BL28 15
CV3, BL23 23 CV4, CV3, BL23 19 CV4, SP9 15
CV4, BL23 22 SP6, BL23 17 CV3, SP6, BL23 15

BL = bladder meridian, CV = conception vessel, SP = spleen meridian, ST = stomach meridian.

3.7. Analysis of association rules of acupoint combination

The “association rule” analysis was performed based on the above frequency analysis. With the same support level of 12 and confidence level of ≥0.6, 16 sets of results were obtained. According to the degree of confidence, Zhongji (CV3), Guanyuan (CV4), and Shenshu (BL23) were the core acupoints. When Sanyinjiao (SP6) and Shuidao (ST28) are selected, Zhongji (CV3) should be compatible (confidence 1). Zhongji (CV3) and Pangguangshu (BL28) are often used in combination with Guanyuan (CV4) (confidence 0.92); Zhongji (CV3), Shenshu (BL23), and Pangguangshu (BL28) are often used with Guanyuan (CV4) (confidence 0.92); Sanyinjiao (SP6) and Yinlingquan (SP9) are often used with Guanyuan (CV4) (confidence 0.92); Taixi (KI3) is often used with Zhongji (CV3) (confidence 0.92); Guanyuan (CV4), Sanyinjiao (SP6), and Shenshu (BL23) are often used in combination with Zhongji (CV3) (confidence 0.92), as shown in Table 6.

Table 6.

Association rules of acupoint combination.

Associated acupoints A Associated acupoints B 1-a Associated acupoints A Associated acupoints B 1-a
SP6, ST28 CV3 1 CV3, SP9 CV4 0.91
CV3, BL28 CV4 0.92 SP9 CV4 0.88
CV3, BL23, BL28 CV4 0.92 SP6, BL23 CV3 0.88
SP6, SP9 CV4 0.92 ST28 CV4 0.87
KI3 CV3 0.92 CV4, BL28 BL23 0.87
CV4, SP6, BL23 CV3 0.92 BL54 CV3 0.86
CV4, CV3, BL28 BL23 0.92 CV4, BL23 CV3 0.86
CV3, BL28 BL23 0.92 CV4, BL23, BL28 CV3 0.85

BL = bladder meridian, CV = conception vessel, KI = kidney meridian, SP = spleen meridian, ST = stomach meridian.

3.8. Network topology analysis of acupoint selection

Based on the above frequency analysis, the support degree was set to 2, and the confidence degree was ≥0.6 to conduct network topology analysis. Figure 4 shows a demonstration of the acupoint combination network. The results demonstrated that the Zhongji (CV3), Guanyuan (CV4), Sanyinjiao (SP6), Shenshu (BL23), and Qihai (CV6) acupoints constituted the core set of acupoints, characterized by their high frequency of combined utilization.

Figure 4.

Figure 4.

Demonstration of the acupoint combination network. Nodes represent acupoints (labeled by code, e.g., CV3, SP6), and edges indicate strong associations (support ≥12, confidence ≥0.6). Node size reflects frequency of use; line thickness corresponds to association strength. Core acupoints include Zhongji (CV3), Guanyuan (CV4), and Sanyinjiao (SP6). CV = conception vessel, SP = spleen meridian

3.9. Clustering analysis of acupoints

TCMISS was used for cluster analysis of the selected 85 articles. The number of clusters was set to 5, and 5 core groups were obtained. Core group 1 comprised Ciliao (BL32), Zhongliao (BL33), Huiyang (BL35), Shenshu (BL23), Pangguangshu (BL28), and Taichong (LR3). Damp-heat accumulation (urgency, dysuria). BL32/BL33 clears dampness via sacral modulation; LR3 drains liver fire. It can tonify the kidney qi, move the bladder meridian qi, activate blood, induce diuresis, and treat stranguria. Core group 2 included Guanyuan (CV4), Zhongji (CV3), Sanyinjiao (SP6), Shenshu (BL23), Yinlingquan (SP9), and Qihai (CV6). Spleen-kidney deficiency (frequency, nocturia). Integrates CV4/CV3 (tonify kidney Yang) + SP6 (fortify spleen) + BL23 (tonify kidney).[29] It can deplete the kidney and fortify the spleen, regulate water passage, clear heat, and drain dampness, a commonly used combination for treating BPH. Reflecting the TCM treatment wisdom of “taking CV and governor’s vessel as the pivot, regulating 3 Yin to benefit water, and balancing Yin and Yang,” a trinity regulatory network of “innate-nurture (kidney)-nurture (spleen)-waterway (bladder)” was constructed. Core group 3 included Zhongji (CV3), Sanyinjiao (SP6), Guanyuan (CV4), Taixi (KI3), Zhibian (BL54), and Taichong (LR3). It mainly focuses on moving the bladder qi, tonifying the kidney qi, and promoting a lower-energizer, which embodies the integrated treatment concept of “tonifying the kidney and soothing the liver-promoting the regulation of the water channel – eliminating Yin and Yang” in the treatment of BPH. Core combination 4 included Guanyuan (CV4), Zhongji (CV3), Qihai (CV6), Qugu (CV2), Shuidao (ST28), and Shenshu (BL23). tonify the kidney and replenish qi, move qi, and drain dampness, reflecting the integrative treatment paradigm of TCM for BPH, namely “CV and governor vessel as key points – gasification sanjiao – Shu and mu Tongtiao.” The core group 5 was Dahe (KI12), Guanyuan (CV4), Taixi (KI3), Qihai (CV6), and Sanyinjiao (SP6), reflecting the integrated treatment concept of “tonify the kidney and Peiyuan – Xie Li Yin Yang – Tongtiao Chongren” in the treatment of BPH. Kidney essence depletion (advanced BPH with atrophy). KI12/KI3 nourish essence; CV4/CV6 consolidate chong-ren vessels. Furthermore, the k-means algorithm and regression model/clustering were combined to demonstrate the effect of clustering, as shown in Figures 5 and 6. Group 1 was close to the regression curve, Groups 2, 3, and 4 were more scattered, and Group 5 had more colors. This indicated that Group 1 was close to the core acupoints of this category, and Group 5 had more prescriptions.

Figure 5.

Figure 5.

Clustering analysis of acupoints (K-means algorithm + cluster). 5 core clusters are color-coded (Group 1: red; Group 2: blue; Group 3: green; Group 4: purple; Group 5: orange). Cluster proximity to the regression curve (black line) indicates centrality of acupoints. Group 1 (red) aligns closely with core therapeutic combinations.

Figure 6.

Figure 6.

Clustering analysis of acupoints (K-means algorithm + Simulation of regression). Scatter plot with regression lines and confidence bands. Groups 2, 3, and 4 show dispersed distributions, while Group 5 (orange) contains the most prescriptions. Symbols (circles, triangles) denote cluster membership.

3.10. Heterogeneity analysis and limitations

The current study acknowledges significant heterogeneity in acupuncture interventions, which may compromise the stability of pooled results. Primary sources of heterogeneity include: Technical variations, notably substantial disparities in electroacupuncture parameters (needling depth, retention time, and treatment course duration); intervention diversity, with 68% of studies incorporating adjunctive therapies (e.g., herbal medicine or tuina); and Inconsistent diagnostic criteria, evidenced by variable IPSS thresholds (8–20 points) for defining BPH severity. These methodological divergences may introduce bias in meta-analyses. Consequently, future trials should standardize intervention protocols – including needling depth and stimulation intensity – while adopting uniform outcome metrics (e.g., IPSS and QOL scores) to enhance evidence consistency.

4. Conclusion

In this review, TCMISS was used to conduct data mining on the literature related to acupuncture for BPH and to study the frequency of acupoint selection, frequency of meridian vessels, distribution rules of body parts, regulations of acupoint selection at specific points, association analysis, and cluster analysis of acupoints. It was concluded that the treatment of BPH: The commonly used acupoints for BPH are Guanyuan (CV4), Zhongji (CV3), Sanyiinjiao (SP6), Qihai (CV6), Shenshu (BL23), Shuidao (ST28), Pangguangshu (BL28), Yinlingquan (SP9), Qugu (CV2), Ciliao (BL32). The most commonly used meridians were the CV (173), bladder meridian (BL) (120), and spleen meridian (SP55). The most commonly used acupoints were the chest and abdomen (EX-CA) and back and waist (EX-BW). The most frequently used acupoints for the treatment of BPH were Guanyuan (CV4), Zhongji (CV3), Sanyinjiao (SP6), and Qugu (CV2). The most frequently used combinations are Zhongji (CV3) and Sanyinjiao (SP6). Guanyuan (CV4), Qihai (CV6); “Guanyuan (CV4), Sanyinjiao (SP6).” 5 core combinations were obtained: core combination 1: Ciliao (BL32), Zhongliao (BL33), Huiyang (BL35), Shenshu (BL23), Pangguangshu (BL28), Taichong (LR3); core group 2: Guanyuan (CV4), Zhongji (CV3), Sanyinjiao (SP6), Shenshu (BL23), Yinlingquan (SP9), and Qihai (CV6). Core Group 3 included Zhongji (CV3), Sanyinjiao (SP6), Guanyuan (CV4), Taixi (KI3), Zhibian (BL54), and Taichong (LR3). Core Group 4 included Guanyuan (CV4), Zhongji (CV3), Qihai (CV6), Qugu (CV2), Shuidao (ST28), and Shenshu (BL23). Core group 5 includes dahe (KI12), Guanyuan (CV4), Taixi (KI3), Qihai (CV6), and Sanyinjiao (SP6).

This study showed that acupuncture showed clinical efficacy for the treatment of BPH. The purpose of this study was to provide a basis and reference for acupoint selection in the treatment of BPH using acupuncture and to provide valuable information for further research and clinical applications. It also provides a reference for acupoint selection and prescription analysis of data-mining technology in the treatment of other diseases. This study elucidates novel therapeutic mechanisms of acupuncture.

Acknowledgments

The authors are grateful to all participants in the present study.

Author contributions

Conceptualization: Chen Guo, Jingwen Huang.

Investigation: Lifeng An.

Methodology: Geling Lu.

Writing – original draft: Chen Guo.

Writing – review & editing: Jingwen Huang.

Abbreviations:

BL
bladder meridian
BPH
benign prostatic hyperplasia
CI
confidence interval
CNKI
China National Knowledge Infrastructure
CV
conception vessel
EA
electroacupuncture
EX-BW
back/waist
EX-CA
chest/abdomen
GB
gallbladder meridian
GV
governor vessel
IPSS
International Prostate Symptom Score
KI
kidney meridian
LI
large intestine meridian
LR
liver meridian
LU
lung meridian
LUTS
lower urinary tract symptoms
PC
pericardium meridian
QOL
quality of life
SP
spleen meridian
ST
stomach meridian
TCM
traditional Chinese medicine
TCMISS
traditional Chinese medicine inheritance support system
TE
triple energizer meridian

The authors have no funding and conflicts of interest to disclose.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

How to cite this article: Guo C, An L, Lu G, Huang J. Acupuncture for benign prostatic hyperplasia in the elderly: A systematic review of acupoints. Medicine 2025;104:32(e43802).

Contributor Information

Chen Guo, Email: guochenzy@163.com.

Lifeng An, Email: anan52ok@163.com.

Geling Lu, Email: lugeling0510@163.com.

References

  • [1].Ye Z, Wang J, Xiao Y, Luo J, Xu L, Chen Z. Global burden of benign prostatic hyperplasia in males aged 60-90 years from 1990 to 2019: results from the global burden of disease study 2019. BMC Urol. 2024;24:193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Homma Y, Gotoh M, Yokoyama O, et al. ; Japanese Urological Association. Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol. 2011;18:741–56. [DOI] [PubMed] [Google Scholar]
  • [3].Phua TJ. The etiology and pathophysiology genesis of benign prostatic hyperplasia and prostate cancer: a new perspective. Medicines (Basel). 2021;8:30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–8. [DOI] [PubMed] [Google Scholar]
  • [5].De Nunzio C, Ahyai S, Autorino R, et al. Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities. Eur Urol. 2011;6:1205–6. [DOI] [PubMed] [Google Scholar]
  • [6].Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am. 2016;43:289–97. [DOI] [PubMed] [Google Scholar]
  • [7].Zhang W, Ding Z, Peng Y, et al. LUTS/BPH increases the risk of depressive symptoms among elderly adults: a 5-year longitudinal evidence from CHARLS. J Affect Disord. 2024;367:210–8. [DOI] [PubMed] [Google Scholar]
  • [8].Foo KT. Current consensus and controversies on male LUTS/BPH (part one). Asian J Urol. 2017;4:137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].N’Dow J. Traditional evidence acquisition powered by Big Data is the next generational paradigm shift in urology. Eur Urol Open Sci. 2023;48:S1. [Google Scholar]
  • [10].Agu PC, Tusubira D, Aja PM. Innovative approaches to benign prostatic hyperplasia management: options beyond conventional treatment strategies. F1000Res. 2024;13:1555. [Google Scholar]
  • [11].Ullah R, Wazir J, Hossain MA, et al. A glimpse into the efficacy of alternative therapies in the management of benign prostatic hyperplasia. Wien Klin Wochenschr. 2021;133:153–62. [DOI] [PubMed] [Google Scholar]
  • [12].Kim HB, Kim YI, Jeon JH, et al. Effectiveness and safety of electroacupuncture and its cotreatment with electronic moxibustion in the treatment of patients with moderate benign prostatic hyperplasia using alpha blocker: study protocol for an assessor-blinded, randomized controlled clinical trial. Medicine (Baltim). 2020;99:e19678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Ifrim Chen F, Antochi AD, Barbilian AG. Acupuncture and the retrospect of its modern research. Rom J Morphol Embryol. 2019;60:411–8. [PubMed] [Google Scholar]
  • [14].Li D, Guo H, Niu L, Yin Q, Zhang Y, Zhuang P. Clinical value-oriented research paradigm about inheritance and innovation development of TCM dominant diseases. Chin Herb Med. 2023;15:476–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Wang Y, Liu B, Yu J, Wu J, Wang J, Liu Z. Electroacupuncture for moderate and severe benign prostatic hyperplasia: a randomized controlled trial. PLoS One. 2013;8:e59449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Yuan H, Wei N, Li Y, et al. Effect of depth of electroacupuncture on the IPSS of patients with benign prostatic hyperplasia. Evid Based Complement Alternat Med. 2019;2019:1439141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Zhang T, Xun YQ, Li B, et al. Effect of fire needle therapy on mild-moderate benign prostatic hyperplasia: protocol for a randomized controlled pilot trial. Medicine (Baltim). 2020;99:e20376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Wang Y, Liu Z, Yu J, Ding Y, Liu X. Efficacy of electroacupuncture at Zhongliao point (BL33) for mild and moderate benign prostatic hyperplasia: study protocol for a randomized controlled trial. Trials. 2011;12:211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Zhu L, Yan Y, Yu J, et al. Electroacupuncture for lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for a randomised controlled trial. BMJ Open. 2024;14:e080743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Li J, Han CH, Cheng XH, et al. Observation on therapeutic effects of elongated needle therapy on dysuria induced by benign prostatic hyperplasia. Zhongguo Zhen Jiu. 2008;28:707–9. [PubMed] [Google Scholar]
  • [21].Bo H, Peng J, Zhuang M, et al. Therapeutic effect of acupuncture and moxa combustion on prostate hyperplasia. Medicine (Baltim). 2022;101:e30925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Creta M, Collà Ruvolo C, Longo N, et al. Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatment. Minerva Urol Nephrol. 2021;73:59–71. [DOI] [PubMed] [Google Scholar]
  • [23].Qin Q, Mo Q, Liu K, He X, Gao X, Zhu B. Acupuncture at homotopic acupoints exerts dual effects on bladder motility in anesthetized rats. BMC Complement Altern Med. 2015;15:267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Li ZF, Zhang R, Zhao GR, Kuang Y. Electroacupuncture inhibits PDK1/Akt/HCN4 pathway to improve neurogenic urinary retention in rats. Zhen Ci Yan Jiu. 2023;48:969–76. [DOI] [PubMed] [Google Scholar]
  • [25].de Groat WC, Griffiths D, Yoshimura N. Neural control of the lower urinary tract. Compr Physiol. 2015;5:327–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Liu X, Zhang CY, Du XY, et al. Acupuncture at Weizhong (BL40) attenuates acetic acid-induced overactive bladder in rats by regulating brain neural activity through the modulation of mast cells and tibial nerves. J Integr Med. 2025;23:46–55. [DOI] [PubMed] [Google Scholar]
  • [27].Hill WG. Control of urinary drainage and voiding. Clin J Am Soc Nephrol. 2015;10:480–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Peng YY, Jing HT, Chen F. Clinical trials of triple-puncture stimulation of Zhibian (BL 54), ctc. plus Moxibustion for benign prostatic hyperplasia. Zhen Ci Yan Jiu. 2015;40:493–6. [PubMed] [Google Scholar]
  • [29].Lv P, Lu Y, Guo W, Zhang R, Zhang T. LU Yonghui’s clinical experience of hierachical acupuncture at acupoints of conception vessel in treatment of benign prostatic hyperplasia. Zhongguo Zhen Jiu. 2024;44:569–73. [DOI] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES